Literature DB >> 12679943

Serum positive cagA in patients with non-ulcer dyspepsia and peptic ulcer disease from two centers in different regions of Turkey.

Ender Serin1, Uğur Yilmaz, Ganiye Künefeci, Birol Ozer, Yuksel Gümürdülü, Mustafa Güçlü, Fazilet Kayaselçuk, Sedat Boyacioğlu.   

Abstract

AIM: To investigate and compare frequencies of serum positive cagA in patients from two separate regions of Turkey who were grouped according to the presence of peptic ulcer disease or non-ulcer dyspepsia.
METHODS: One hundred and eighty Helicobacter pylori-positive patients with peptic ulcer disease or non-ulcer dyspepsia were included in the study. One hundred and fourteen patients had non-ulcer dyspepsia and 66 had peptic ulcer disease (32 with gastric ulcers and/or erosions and 34 with duodenal ulcers). Each patient was tested for serum antibody to H. pylori cagA protein by enzyme immunoassay.
RESULTS: The total frequency of serum positive cagA in the study group was 97.2 %. The rates in the patients with peptic ulcers and in those with non-ulcer dyspepsia were 100 % and 95.6 %, respectively. These results were similar to those reported in Asian studies, but higher than those that have been noted in other studies from Turkey and Western countries.
CONCLUSION: The high rates of serum positive cagA in these patients with peptic ulcer disease and non-ulcer dyspepsia were similar to results reported in Asia. The fact that there was high seroum prevalence regardless of ulcer status suggests that factors other than cagA might be responsible for ulceration or other types of severe pathology in H. pylori-positive individuals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679943      PMCID: PMC4611460          DOI: 10.3748/wjg.v9.i4.833

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

1.  Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking.

Authors:  J H Kurata; A N Nogawa
Journal:  J Clin Gastroenterol       Date:  1997-01       Impact factor: 3.062

2.  Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis.

Authors:  V J Warburton; S Everett; N P Mapstone; A T Axon; P Hawkey; M F Dixon
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

3.  Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

Authors:  J E Crabtree; J D Taylor; J I Wyatt; R V Heatley; T M Shallcross; D S Tompkins; B J Rathbone
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

4.  Analysis of the expression of CagA and VacA and the vacuolating activity in 167 isolates from patients with either peptic ulcers or non-ulcer dyspepsia.

Authors:  T Takata; S Fujimoto; K Anzai; T Shirotani; M Okada; Y Sawae; J Ono
Journal:  Am J Gastroenterol       Date:  1998-01       Impact factor: 10.864

5.  The status of the cagA gene does not predict Helicobacter pylori-associated peptic ulcer disease in Singapore.

Authors:  J Hua; P Y Zheng; K G Yeoh; B Ho
Journal:  Microbios       Date:  2000

6.  Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma.

Authors:  J Rudi; C Kolb; M Maiwald; I Zuna; A von Herbay; P R Galle; W Stremmel
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

7.  Genetic analysis of the cytotoxin-associated gene and the vacuolating toxin gene in Helicobacter pylori strains isolated from Taiwanese patients.

Authors:  J C Yang; T H Wang; H J Wang; C H Kuo; J T Wang; W C Wang
Journal:  Am J Gastroenterol       Date:  1997-08       Impact factor: 10.864

8.  Helicobacter pylori and atrophic gastritis: importance of the cagA status.

Authors:  E J Kuipers; G I Pérez-Pérez; S G Meuwissen; M J Blaser
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

9.  Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype.

Authors:  J E Crabtree; A Covacci; S M Farmery; Z Xiang; D S Tompkins; S Perry; I J Lindley; R Rappuoli
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

Review 10.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

Authors:  M F Dixon; R M Genta; J H Yardley; P Correa
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

View more
  4 in total

1.  The significance of E266K polymorphism in the NOD1 gene on Helicobacter pylori infection: an effective force on pathogenesis?

Authors:  Banu Kara; Hikmet Akkiz; Figen Doran; Suleyman Bayram; Eren Erken; Yuksel Gumurdullu; Macit Sandikci
Journal:  Clin Exp Med       Date:  2009-10-31       Impact factor: 3.984

2.  Detection of H. pylori infection by ELISA and Western blot techniques and evaluation of anti CagA seropositivity in adult Turkish dyspeptic patients.

Authors:  Ozlem Yilmaz; Nazime Sen; Ahmet Ali Küpelioğlu; Ilkay Simşek
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

3.  Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer.

Authors:  Yusuf Erzin; Sibel Altun; Ahmet Dobrucali; Mustafa Aslan; Sibel Erdamar; Ahmet Dirican; Murat Tuncer; Bekir Kocazeybek
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

4.  Helicobacter pylori virulence factors in duodenal ulceration: A primary cause or a secondary infection causing chronicity.

Authors:  Frank I Tovey; Michael Hobsley; John Holton
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.